Type
|
Public company |
---|---|
Traded as | NYSE: UDR S&P 500 Index component |
Industry | Real estate investment trust |
Founded | 1972 (1972) |
Headquarters | Highlands Ranch, Colorado |
Key people
|
Thomas W. Toomey, CEO James D. Klingbeil, Chairman Joseph D. Fisher. CFO |
Revenue | $0.959 billion (2016) |
Net income
|
$0.320 billion (2016) |
Total assets | $7.679 billion (2016) |
Total equity | $3.096 billion (2016) |
Number of employees
|
1,550 (2016) |
Website | www |
UDR Inc. (formerly United Dominion Realty) is a publicly-traded real estate investment trust based in Highlands Ranch, Colorado that invests in apartments.
As of December 31, 2016, the company owned interests in 127 apartment communities containing 39,454 apartment units.
The company was founded in 1972.
On January 13, 1978, the company became a public company via an initial public offering.
In 2007, the company sold 9 apartment complexes containing 2,710 apartment units for $281 million.
In 2008, the company sold a healthcare facility in Glen Burnie, Maryland for $27.36 million.
In September 2010, the company announced the acquisition of 5 properties for $455.1 million.
In June 2011, the company sold a 185-unit apartment complex in Washington, D.C. for $104 million.
In 2011, the company acquired several properties in New York City, including 95 Wall Street for $325 million and 21 Chelsea for $138 million.
In January 2012, in partnership with Metlife, the company acquired Columbus Square, New York City for $630 million.
In December 2012, Tom Herzog was named chief financial officer of the company.
In 2014, the company sold a portfolio of properties in Tampa, Florida for $80 million.
In 2015, the company acquired 6 properties in the Washington, D.C. metropolitan area from Home Properties for $901 million and sold 8 properties for $284 million.
In March 2016, the company was added to the S&P 500 Index.
In May 2016, the company sold a shopping center in Bellevue, Washington for $45.35 million. The center had been acquired 10 years earlier for $31.5 million.
Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-10-24 | Future report Set alerts | |
Q2 2022 | 2022-07-26 | 0.01 | 0.01 |
Q1 2022 | 2022-04-26 | 0.04 | 0.04 |
Q4 2021 | 2022-02-08 | 0.37 | 0.37 |
Q3 2021 | 2021-10-26 | 0.06 | 0.06 |
Q2 2021 | 2021-07-28 | 0.04 | 0.04 |
Q1 2021 | 2021-04-27 | 0.01 | 0.01 |
Q4 2020 | 2021-02-09 | 0.09 | 0.09 |
Q3 2020 | 2020-10-29 | -0.09 | -0.09 |
Q2 2020 | 2020-07-28 | 0.19 | 0.19 |
2016-04-11 | Downgrade | Bank of America | Buy to Underperform | |
2016-04-11 | Downgrade | Bank of America Corp. | Buy to Underperform | |
2016-03-21 | Downgrade | Mizuho | Buy to Neutral | $39.00 to $41.00 |
2016-03-21 | Boost Price Target | Evercore ISI | Hold | $37.00 to $38.00 |
2016-03-07 | Upgrade | BMO Capital Markets | Market Perform to Outperform | $39.00 to $40.00 |
2016-02-23 | Boost Price Target | Barclays | Equal Weight | $36.00 to $37.00 |
2016-02-23 | Boost Price Target | Barclays PLC | Equal Weight | $36.00 to $37.00 |
2016-02-11 | Reiterated Rating | RBC Capital | Sector Perform | $38.00 to $37.00 |
2016-02-11 | Reiterated Rating | Royal Bank Of Canada | Sector Perform | $38.00 to $37.00 |
2016-02-08 | Lower Price Target | Mizuho | Buy | $41.00 to $39.00 |
2016-02-03 | Reiterated Rating | Cantor Fitzgerald | Buy | $39.00 |
2016-01-19 | Downgrade | JMP Securities | Outperform to Market Perform | $40.00 |
2016-01-12 | Downgrade | Cowen and Company | Outperform to Market Perform | $35.50 to $37.00 |
2015-12-22 | Reiterated Rating | Cantor Fitzgerald | Buy | |
2015-12-18 | Reiterated Rating | Mizuho | Buy | $39.00 to $41.00 |
2015-12-17 | Downgrade | Robert W. Baird | Outperform to Neutral | $37.00 |
2015-12-16 | Boost Price Target | BMO Capital Markets | Market Perform | $39.00 |
2015-11-16 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $36.00 to $38.00 |
2015-11-10 | Initiated Coverage | BB&T Corp. | Underweight | $36.50 |
2015-11-09 | Downgrade | Miller Tabak | Hold to Sell | |
2015-11-09 | Boost Price Target | RBC Capital | Sector Perform | $37.00 to $38.00 |
2015-11-06 | Boost Price Target | Barclays | Equal Weight | $37.00 to $38.00 |
2015-10-28 | Boost Price Target | JMP Securities | $39.00 to $40.00 | |
2015-10-27 | Boost Price Target | Stifel Nicolaus | Buy | $38.00 to $39.00 |
2015-10-27 | Upgrade | Credit Suisse | Underperform to Neutral | $36.50 to $38.00 |
2015-10-27 | Upgrade | Credit Suisse Group AG | Underperform to Neutral | $36.50 to $38.00 |
2015-10-20 | Boost Price Target | JMP Securities | $37.00 to $39.00 | |
2015-10-20 | Boost Price Target | Barclays | Equal Weight | $35.00 to $37.00 |
2015-10-16 | Boost Price Target | Morgan Stanley | Equal Weight | $38.00 to $40.00 |
2015-09-15 | Initiated Coverage | JMP Securities | Outperform | $37.00 |
2015-09-09 | Upgrade | Miller Tabak | Sell to Hold | |
2015-09-08 | Lower Price Target | Evercore ISI | Hold | $37.00 to $35.00 |
2015-09-08 | Lower Price Target | Evercore Partners Inc. | Hold | $37.00 to $35.00 |
2015-08-20 | Downgrade | Credit Suisse | Neutral to Underperform | $36.00 |
2015-08-14 | Boost Price Target | Barclays | Equal Weight | $34.00 to $35.00 |
2015-08-03 | Boost Price Target | RBC Capital | Sector Perform | $36.00 to $37.00 |
2015-07-28 | Reiterated Rating | Cantor Fitzgerald | Buy | $37.00 |
2015-07-20 | Initiated Coverage | SunTrust | Neutral | $37.00 |
2015-07-20 | Lower Price Target | Barclays | Equal Weight | $35.00 to $34.00 |
2015-07-20 | Initiated Coverage | SunTrust Banks Inc. | Neutral | $37.00 |
2015-07-02 | Reiterated Rating | Evercore ISI | Hold | $35.00 to $37.00 |
2015-06-24 | Boost Price Target | Cantor Fitzgerald | Buy | $35.00 to $37.00 |
2015-06-12 | Upgrade | Mizuho | Neutral to Buy | |
2015-06-12 | Upgrade | Cowen and Company | Market Perform to Outperform | $34.50 to $35.50 |
2015-06-09 | Reiterated Rating | Evercore ISI | Hold | $36.00 to $35.00 |
2015-05-22 | Boost Price Target | Barclays | Equal Weight | $34.00 to $35.00 |
2015-05-16 | Reiterated Rating | Robert W. Baird | Outperform | |
2015-05-12 | Reiterated Rating | RBC Capital | Sector Perform | $36.00 |
2015-05-04 | Reiterated Rating | BMO Capital Markets | Market Perform | $34.50 to $35.00 |
2015-05-04 | Upgrade | Mizuho | Neutral to Buy | $32.00 to $37.00 |
2015-04-30 | Boost Price Target | Citigroup Inc. | Neutral | $33.00 to $35.00 |
2015-04-29 | Reiterated Rating | Cantor Fitzgerald | Buy | $35.00 |
2015-04-28 | Boost Price Target | Stifel Nicolaus | Buy | $36.00 to $38.00 |
2015-04-09 | Initiated Coverage | Janney Montgomery Scott | Neutral | $34.00 |
2015-04-08 | Initiated Coverage | BMO Capital Markets | Market Perform | $34.50 |
2015-03-16 | Initiated Coverage | Robert W. Baird | Outperform | $37.00 |
2015-03-05 | Downgrade | Evercore ISI | Buy to Hold | |
2015-02-05 | Lower Price Target | Citigroup Inc. | Buy | $60.00 to $56.00 |
2015-02-03 | Reiterated Rating | Stifel Nicolaus | Buy | $32.50 to $36.00 |
2015-02-03 | Reiterated Rating | Cantor Fitzgerald | Buy | $34.00 |
2015-02-02 | Downgrade | Miller Tabak | Hold to Sell | |
2014-11-24 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $31.00 to $33.00 |
2014-11-11 | Initiated Coverage | Credit Suisse | Neutral | |
2014-10-31 | Reiterated Rating | Citigroup Inc. | Neutral | $30.00 to $32.00 |
2014-10-02 | Upgrade | Cantor Fitzgerald | Hold to Buy | |
2014-08-25 | Initiated Coverage | Mizuho | Neutral | $31.00 |
2014-08-18 | Reiterated Rating | KeyBanc | Buy | $32.00 to $33.00 |
2014-08-18 | Reiterated Rating | KeyCorp | Buy | $32.00 to $33.00 |
2014-08-05 | Boost Price Target | RBC Capital | Sector Perform | $28.00 to $31.00 |
2014-07-21 | Boost Price Target | Barclays | Equal Weight | $27.00 to $29.00 |
2014-06-20 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $28.00 to $29.00 |
2014-05-02 | Reiterated Rating | Citigroup Inc. | Hold | $27.00 |
2013-12-12 | Upgrade | KeyBanc | Hold to Buy | |
2013-11-18 | Upgrade | Evercore ISI | Neutral to Buy |
2016-04-11 | Downgrade | Bank of America | Buy to Underperform | |
2016-04-11 | Downgrade | Bank of America Corp. | Buy to Underperform | |
2016-03-21 | Downgrade | Mizuho | Buy to Neutral | $39.00 to $41.00 |
2016-03-21 | Boost Price Target | Evercore ISI | Hold | $37.00 to $38.00 |
2016-03-07 | Upgrade | BMO Capital Markets | Market Perform to Outperform | $39.00 to $40.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In UDR 338 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
Vanguard Group, Inc | 52.11M |
COHEN & STEERS CAPITAL MANAGEMENT INC | 37.48M |
COHEN & STEERS INC | 36.57M |
BlackRock Inc. | 34.24M |
STATE STREET CORP | 20.23M |
Invesco Ltd. | 12.49M |
FMR LLC | 10.95M |
BlackRock Institutional Trust Company, N.A. | 10.56M |
BlackRock Fund Advisors | 10.52M |
JPMORGAN CHASE & CO | 7.24M |
Daiwa Securities Group Inc. | 7.14M |
GEODE CAPITAL MANAGEMENT, LLC | 6.73M |
DIMENSIONAL FUND ADVISORS LP | 4.62M |
NORTHERN TRUST CORP | 4.37M |
BlackRock Group LTD | 4.20M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
TOOMEY THOMAS W Chief Executive Officer | 0.44% (1119390) | RYL / UDR / |
Troupe Warren L Senior Exec VP | 0.21% (528378) | UDR / |
GROVE JON A | 0.18% (452808) | UDR / |
Davis Jerry A Senior Vice President | 0.10% (244669) | UDR / |
KLINGBEIL JAMES D | 0.06% (153503) | UDR / |
ALCOCK HARRY G Senior Vice President | 0.05% (136123) | UDR / |
SANDLER MARK J | 0.04% (104801) | UDR / |
HERZOG THOMAS M SVP-Chief Financial Officer | 0.04% (97185) | HCP / UDR / |
FREEMAN ROBERT P | 0.04% (93404) | UDR / |
SAGALYN LYNNE B | 0.04% (91949) | BXMT / UDR / |
CATTANACH KATHERINE A | 0.02% (56887) | UDR / |
FOSS ERIC J | 0.02% (39316) | CI / UDR / |
Fisher Joseph D SVP-Chief Financial Officer | 0.01% (33781) | UDR / |
CULWELL MARK M Senior Vice President | 0.01% (33720) | UDR / |
Wesson Randall Scott Senior Vice President - CIO | 0.01% (32032) | UDR / |
Cantor H Andrew Vice President | 0.01% (31055) | UDR / |
Johnston Shawn G VP-Controller | 0.01% (13349) | HCP / UDR / |
Williams Elaine A VP-Property Operations | 0.01% (13062) | UDR / |